%0 Journal Article %J Lancet %D 2002 %T Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. %A Egger, Matthias %A May, Margaret %A Chêne, Geneviève %A Phillips, Andrew N %A Ledergerber, Bruno %A Dabis, François %A Costagliola, Dominique %A d'Arminio Monforte, Antonella %A de Wolf, Frank %A Reiss, Peter %A Lundgren, Jens D %A Justice, Amy C %A Staszewski, Schlomo %A Leport, Catherine %A Hogg, Robert S %A Sabin, Caroline A %A Gill, M John %A Salzberger, Bernd %A Sterne, Jonathan A C %K Adolescent %K Adult %K Antiretroviral Therapy, Highly Active %K CD4 Lymphocyte Count %K Europe %K Female %K HIV Infections %K HIV-1 %K Humans %K Male %K Middle Aged %K Prognosis %K Prospective Studies %K Risk Factors %K Survival Analysis %K United States %K Viral Load %N 9327 %P 119-29 %R 10.1016/S0140-6736(02)09411-4 %V 360 %X Insufficient data are available from single cohort studies to allow estimation of the prognosis of HIV-1 infected, treatment-naive patients who start highly active antiretroviral therapy (HAART). The ART Cohort Collaboration, which includes 13 cohort studies from Europe and North America, was established to fill this knowledge gap. %8 2002 Jul 13